Collplant Biotechnologies Ltd current report, Q2 FY2018

CollPlant Biotechnologies Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by CollPlant Holdings Ltd. (also referred to as CollPlant Biotechnologies Ltd.) on May 1, 2018. The filing serves to distribute a press release dated May 1, 2018, regarding the completion of the third closing of the "Alpha Investment."

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing incorporating a press release about a capital event rather than a financial statement.

Material Changes

The primary material event reported is the completion of the third closing of the Alpha Investment. No comparative financial data or changes in operational metrics versus prior periods are included in this specific filing text.

Guidance, Outlook, and Risks

The filing does not contain management commentary on future guidance, outlook, specific risks, or contingencies beyond the announcement of the investment closing. No unusual items are detailed in the provided text.

Investor Verification Checklist

  • Verify the total aggregate amount raised through the Alpha Investment across all closings.
  • Confirm the specific terms and conditions of the third closing of the Alpha Investment.
  • Review the full text of the press release (Exhibit 99.1) for details on the use of proceeds.
  • Check subsequent filings for updated financial statements reflecting the capital raise.